financetom
Business
financetom
/
Business
/
Expect financial year 2023-24 margins at 25 percent, High end testing aiding revenue per patient: Dr. Lal PathLabs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Expect financial year 2023-24 margins at 25 percent, High end testing aiding revenue per patient: Dr. Lal PathLabs
May 12, 2023 2:42 AM

"Expect financial year 2023-24 margins at 25 percent" Om Manchanda, Dr. Lal PathLabs said in an interaction with CNBC-TV18 on Friday. The diagnostics and related healthcare tests provider declared its fourth quarter results on Thursday and the stock is trading 1 percent higher on the exchanges on Friday at 10:30 am.

Share Market Live

NSE

The company's consolidated net profit declined 7.5 percent to Rs 56.7 crore in the fourth quarter ended March 31, 2022 — much lower than CNBC-TV18's poll of Rs 65.7 crore. This is the sixth consecutive fall in quarterly profit as a continued slide in income from COVID-related testing outpaced growth in its core business. Revenue from operations, however, rose to Rs 491 crore in the fourth quarter as against Rs 485.5 crore in the year-ago period, Dr Lal Pathlabs said in a statement.

Dr. Lal PathLabs is the first among its peers to report results and will set the tone for an intensely competitive industry that made large gains during the pandemic.

Dr. Lal PathLabs management while interacting with CNBC-TV18 on Friday added that the competitive intensity has reduced and witnessed a flat pattern between third and fourth quarters of 2022-23 for non-COVID revenue.

Manchanda further says that revenue per patient has been aided by bundled packages and mix changes. "The high end testing has aided the revenue per patient ratio for the company". It is also confident of sustaining growth seen in the past, while volume growth is expected at 8 to 9 percent.

The company further adds that screening packages are gaining ground. It recently launched a reference lab In Mumbai. The diagnostics and related healthcare tests provider expects to clock 25 percent margins in FY compared with 23.5 clocked in fourth quarter of financial year 2022-23.

In the recently hosted conference call for analysts, the company said its gross margins expanded 190bps year on year due to a change in test mix and price hikes taken in February 2023. Furthermore, specialized tests have scaled up significantly and are expanding to newer geographies including tier 2-3 towns. The industry growth is normalizing to 10 to 11 percent and the quality of assets available for inorganic growth has declined.

(Edited by : Vahishta Unwalla)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Snap Under European Probe Over Child Safety
Snap Under European Probe Over Child Safety
Mar 26, 2026
08:09 AM EDT, 03/26/2026 (MT Newswires) -- Snap (SNAP) is under investigation by the European Commission for allegations of failing to protect the safety and privacy of children using the platform, the regulator said Thursday. The European Commission said the company may have violated the bloc's Digital Services Act by exposing minors to grooming attempts and recruitment for criminal purposes,...
Equinor Completes Investigation Into Mongstad Chemical Exposure Incident
Equinor Completes Investigation Into Mongstad Chemical Exposure Incident
Mar 26, 2026
08:10 AM EDT, 03/26/2026 (MT Newswires) -- Equinor ( EQNR ) said Thursday it has completed an internal investigation into a chemical exposure incident at its Mongstad, Norway refinery in October 2025. The company said personnel were exposed to elevated benzene levels during work on a measuring instrument, with two employees experiencing discomfort and one briefly absent from work. The...
Plantro Calls on Ag Growth International to Commence a Formal Sale Process of the Company to Maximize Value for Shareholders
Plantro Calls on Ag Growth International to Commence a Formal Sale Process of the Company to Maximize Value for Shareholders
Mar 26, 2026
ST. HELIER, Jersey, March 26, 2026 (GLOBE NEWSWIRE) -- Plantro Ltd. (“Plantro”), a shareholder of Ag Growth International Inc. ( AGGZF ) (AGI or the Company) today called on the board of directors of AGI (the “Board”) to commence a formal sale process soliciting bids to acquire the entire Company. Following AGI’s release of its fourth quarter 2025 earnings report...
REX American Resources Fiscal Q4 Earnings Rise, Revenue Falls
REX American Resources Fiscal Q4 Earnings Rise, Revenue Falls
Mar 26, 2026
08:07 AM EDT, 03/26/2026 (MT Newswires) -- REX American Resources ( REX ) reported fiscal Q4 earnings Thursday of $1.32 per diluted share, up from $0.31 a year earlier. Revenue for the quarter ended Jan. 31 was $158 million, compared with $158.2 million a year earlier. Analysts' estimates were not available for comparison. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved